Cyclohexanes
-
Subject Areas on Research
- Antiangiogenic agents protect liver sinusoidal lining cells from cold preservation injury in rat liver transplantation.
- Drugs derived from cannabinoids. 4. Effect of alkyl substitution in sulfur and carbocyclic analogs.
- Effect of valsartan on the incidence of diabetes and cardiovascular events.
- Effects of changes in potassium with valsartan use on diabetes risk: Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial.
- Evidence for a radical mechanism of halogenation of monochlorodimedone catalyzed by chloroperoxidase.
- Genotypic analysis of the V3 region of HIV from virologic nonresponders to maraviroc-containing regimens reveals distinct patterns of failure.
- HIV entry inhibitors: progress in development and application.
- HIV-1 gp120 as a therapeutic target: navigating a moving labyrinth.
- Identification of in vitro rat metabolites of 1-phenylcyclohexene.
- Impact of baseline physical activity and diet behavior on metabolic syndrome in a pharmaceutical trial: results from NAVIGATOR.
- Incidence of atrial fibrillation in a population with impaired glucose tolerance: the contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.
- International Variation in Outcomes Among People with Cardiovascular Disease or Cardiovascular Risk Factors and Impaired Glucose Tolerance: Insights from the NAVIGATOR Trial.
- Ketamine ("Ketalar"): a safer anaesthetic for ECT.
- Microsporidian methionine aminopeptidase type 2.
- Oxybutynin chloride in control of post-trasurethral vesical pain and spasm.
- Oxybutynin chloride in the management of idiopathic detrusor instability.
- Phencyclidine and phenylcyclohexene disposition after smoking phencyclidine.
- Physical activity as a determinant of fasting and 2-h post-challenge glucose: a prospective cohort analysis of the NAVIGATOR trial.
- Physiological mechanisms of sustained fumagillin-induced weight loss.
- Predictors of incident heart failure hospitalizations among patients with impaired glucose tolerance: insight from the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research study.
- Predictors of stroke in patients with impaired glucose tolerance: results from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.
- Prospective relationships between body weight and physical activity: an observational analysis from the NAVIGATOR study.
- Psychosis and ketamine.
- Psychosis and ketamine.
- Regression of metastatic breast cancer in a patient treated with the anti-angiogenic drug TNP-470.
- Reliable genotypic tropism tests for the major HIV-1 subtypes.
- Role of diuretics, β blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study.
- Toxicity and pharmacokinetics of the antibiotic fumagillin in yearling rainbow trout (Salmo gairdneri).
- Transport properties of the calcium ionophore ETH-129.
- Venous thromboembolism and cardiovascular risk: results from the NAVIGATOR trial.